TreeWAS – Variant ID: rs190999252

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
D10-D36 Benign neoplasms	0.177	0.823
Chapter II Neoplasms	0.175	0.825
D25 Leiomyoma of uterus	0.164	0.836
D37-D48 Neoplasms of uncertain or unknown behaviour	0.160	0.840
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.157	0.843
C64-C68 Malignant neoplasms of urinary tract	0.157	0.843
D25.2 Subserosal leiomyoma of uterus	0.155	0.845
C43-C44 Melanoma and other malignant neoplasms of skin	0.152	0.848
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.149	0.851
D24 Benign neoplasm of breast	0.147	0.853
D21 Other benign neoplasms of connective and other soft tissue	0.146	0.854
D11 Benign neoplasm of major salivary glands	0.145	0.855
C67 Malignant neoplasm of bladder	0.145	0.855
D28 Benign neoplasm of other and unspecified female genital organs	0.143	0.857
C51-C58 Malignant neoplasms of female genital organs	0.142	0.858
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.141	0.859
D33 Benign neoplasm of brain and other parts of central nervous system	0.140	0.859
C44 Other malignant neoplasms of skin	0.139	0.861
D00-D09 In situ neoplasms	0.139	0.861
D13.1 Stomach	0.138	0.862
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.136	0.864
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.136	0.864
D22 Melanocytic naevi	0.134	0.866
D36 Benign neoplasm of other and unspecified sites	0.133	0.867
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.132	0.868
D35 Benign neoplasm of other and unspecified endocrine glands	0.131	0.868
D18 Haemangioma and lymphangioma, any site	0.131	0.869
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.130	0.870
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.130	0.870
D25.9 Leiomyoma of uterus, unspecified	0.129	0.871
D45 Polycythaemia vera	0.128	0.872
D17 Benign lipomatous neoplasm	0.127	0.873
C66 Malignant neoplasm of ureter	0.127	0.873
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.127	0.873
D31 Benign neoplasm of eye and adnexa	0.127	0.873
D30 Benign neoplasm of urinary organs	0.127	0.873
D29 Benign neoplasm of male genital organs	0.127	0.873
D26 Other benign neoplasms of uterus	0.127	0.873
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.127	0.873
D19 Benign neoplasm of mesothelial tissue	0.127	0.873
D16 Benign neoplasm of bone and articular cartilage	0.127	0.873
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.127	0.873
D14 Benign neoplasm of middle ear and respiratory system	0.127	0.873
D10 Benign neoplasm of mouth and pharynx	0.127	0.873
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.126	0.873
D13.2 Duodenum	0.126	0.874
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.125	0.874
C40-C41 Malignant neoplasms of bone and articular cartilage	0.125	0.874
C15-C26 Malignant neoplasms of digestive organs	0.125	0.875
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.124	0.875
C44.2 Skin of ear and external auricular canal	0.123	0.876
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.123	0.877
D11.0 Parotid gland	0.122	0.878
C80 Malignant neoplasm without specification of site	0.122	0.878
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.120	0.880
C77.5 Intrapelvic lymph nodes	0.120	0.880
C67.5 Bladder neck	0.119	0.880
D22.3 Melanocytic naevi of other and unspecified parts of face	0.119	0.880
D28.2 Uterine tubes and ligaments	0.119	0.881
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.118	0.882
C55 Malignant neoplasm of uterus, part unspecified	0.118	0.882
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.117	0.883
D32 Benign neoplasm of meninges	0.117	0.883
C44.6 Skin of upper limb, including shoulder	0.116	0.883
C67.6 Ureteric orifice	0.116	0.884
D34 Benign neoplasm of thyroid gland	0.116	0.884
C67.9 Bladder, unspecified	0.116	0.884
D23 Other benign neoplasms of skin	0.115	0.885
D46 Myelodysplastic syndromes	0.115	0.885
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.115	0.885
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.115	0.885
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.115	0.885
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.115	0.885
D33.3 Cranial nerves	0.115	0.885
C83 Diffuse non-Hodgkin's lymphoma	0.115	0.885
D25.0 Submucous leiomyoma of uterus	0.114	0.885
C67.2 Lateral wall of bladder	0.114	0.886
C44.1 Skin of eyelid, including canthus	0.114	0.886
D13.9 Ill-defined sites within the digestive system	0.113	0.887
D13.7 Endocrine pancreas	0.113	0.887
D13.6 Pancreas	0.113	0.887
D13.5 Extrahepatic bile ducts	0.113	0.887
D13.4 Liver	0.113	0.887
D13.3 Other and unspecified parts of small intestine	0.113	0.887
D13.0 Oesophagus	0.113	0.887
C68 Malignant neoplasm of other and unspecified urinary organs	0.113	0.887
C65 Malignant neoplasm of renal pelvis	0.113	0.887
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.113	0.887
C44.5 Skin of trunk	0.112	0.888
D04 Carcinoma in situ of skin	0.111	0.889
D17.7 Benign lipomatous neoplasm of other sites	0.111	0.889
C77.4 Inguinal and lower limb lymph nodes	0.109	0.891
D27 Benign neoplasm of ovary	0.109	0.891
D07 Carcinoma in situ of other and unspecified genital organs	0.108	0.891
D47.3 Essential (haemorrhagic) thrombocythaemia	0.108	0.892
C77.8 Lymph nodes of multiple regions	0.108	0.892
D22.5 Melanocytic naevi of trunk	0.108	0.892
C76 Malignant neoplasm of other and ill-defined sites	0.107	0.893
C44.4 Skin of scalp and neck	0.107	0.893
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.106	0.894
C54 Malignant neoplasm of corpus uteri	0.106	0.894
C01 Malignant neoplasm of base of tongue	0.105	0.895
D21.9 Connective and other soft tissue, unspecified	0.105	0.895
D21.6 Connective and other soft tissue of trunk, unspecified	0.105	0.895
D21.5 Connective and other soft tissue of pelvis	0.105	0.895
D21.4 Connective and other soft tissue of abdomen	0.105	0.895
D21.3 Connective and other soft tissue of thorax	0.105	0.895
D21.2 Connective and other soft tissue of lower limb, including hip	0.105	0.895
D21.0 Connective and other soft tissue of head, face and neck	0.105	0.895
D09 Carcinoma in situ of other and unspecified sites	0.105	0.895
D11.9 Major salivary gland, unspecified	0.104	0.896
D11.7 Other major salivary glands	0.104	0.896
D23.1 Skin of eyelid, including canthus	0.104	0.896
C67.8 Overlapping lesion of bladder	0.104	0.896
C67.7 Urachus	0.104	0.896
C67.4 Posterior wall of bladder	0.104	0.896
C67.3 Anterior wall of bladder	0.104	0.896
C67.1 Dome of bladder	0.104	0.896
C67.0 Trigone of bladder	0.104	0.896
D35.0 Adrenal gland	0.103	0.896
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.103	0.897
D25.1 Intramural leiomyoma of uterus	0.103	0.897
C91 Lymphoid leukaemia	0.103	0.897
C81 Hodgkin's disease	0.103	0.897
D38.1 Trachea, bronchus and lung	0.103	0.897
D28.9 Female genital organ, unspecified	0.103	0.897
D28.7 Other specified female genital organs	0.103	0.897
D28.1 Vagina	0.103	0.897
D28.0 Vulva	0.103	0.897
C53 Malignant neoplasm of cervix uteri	0.102	0.897
D36.1 Peripheral nerves and autonomic nervous system	0.102	0.898
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.102	0.898
C57 Malignant neoplasm of other and unspecified female genital organs	0.102	0.898
C51 Malignant neoplasm of vulva	0.102	0.898
C58 Malignant neoplasm of placenta	0.102	0.898
C52 Malignant neoplasm of vagina	0.102	0.898
C15 Malignant neoplasm of oesophagus	0.102	0.898
C71 Malignant neoplasm of brain	0.102	0.898
D03 Melanoma in situ	0.101	0.899
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.101	0.899
C95 Leukaemia of unspecified cell type	0.101	0.899
C94 Other leukaemias of specified cell type	0.101	0.899
C93 Monocytic leukaemia	0.101	0.899
C88 Malignant immunoproliferative diseases	0.101	0.899
C86 Other specified types of T/NK-cell lymphoma	0.101	0.899
C84 Peripheral and cutaneous T-cell lymphomas	0.101	0.899
C77.3 Axillary and upper limb lymph nodes	0.101	0.899
C19 Malignant neoplasm of rectosigmoid junction	0.101	0.899
C44.7 Skin of lower limb, including hip	0.101	0.899
D33.9 Central nervous system, unspecified	0.101	0.899
D33.7 Other specified parts of central nervous system	0.101	0.899
D33.4 Spinal cord	0.101	0.899
D33.2 Brain, unspecified	0.101	0.899
D33.1 Brain, infratentorial	0.101	0.899
D33.0 Brain, supratentorial	0.101	0.899
C77.2 Intra-abdominal lymph nodes	0.101	0.899
C50-C50 Malignant neoplasm of breast	0.101	0.899
C90 Multiple myeloma and malignant plasma cell neoplasms	0.101	0.899
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.101	0.899
C09 Malignant neoplasm of tonsil	0.100	0.899
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.100	0.899
C80.0 Malignant neoplasm, primary site unknown, so stated	0.100	0.899
C44.9 Malignant neoplasm of skin, unspecified	0.100	0.900
C44.8 Overlapping lesion of skin	0.100	0.900
C44.0 Skin of lip	0.100	0.900
D22.0 Melanocytic naevi of lip	0.100	0.900
D02 Carcinoma in situ of middle ear and respiratory system	0.100	0.900
D01 Carcinoma in situ of other and unspecified digestive organs	0.100	0.900
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.100	0.900
C77.0 Lymph nodes of head, face and neck	0.099	0.901
D18.0 Haemangioma, any site	0.098	0.902
C34 Malignant neoplasm of bronchus and lung	0.098	0.902
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.097	0.902
C13 Malignant neoplasm of hypopharynx	0.097	0.902
C11 Malignant neoplasm of nasopharynx	0.097	0.902
C10 Malignant neoplasm of oropharynx	0.097	0.902
C08 Malignant neoplasm of other and unspecified major salivary glands	0.097	0.902
C06 Malignant neoplasm of other and unspecified parts of mouth	0.097	0.902
C05 Malignant neoplasm of palate	0.097	0.902
C04 Malignant neoplasm of floor of mouth	0.097	0.902
C03 Malignant neoplasm of gum	0.097	0.902
C02 Malignant neoplasm of other and unspecified parts of tongue	0.097	0.902
C00 Malignant neoplasm of lip	0.097	0.902
C12 Malignant neoplasm of pyriform sinus	0.097	0.902
C07 Malignant neoplasm of parotid gland	0.097	0.902
C56 Malignant neoplasm of ovary	0.097	0.903
C92 Myeloid leukaemia	0.097	0.903
D39.1 Ovary	0.097	0.903
C43 Malignant melanoma of skin	0.097	0.903
D05 Carcinoma in situ of breast	0.097	0.903
D22.9 Melanocytic naevi, unspecified	0.096	0.903
D22.2 Melanocytic naevi of ear and external auricular canal	0.096	0.903
D36.9 Benign neoplasm of unspecified site	0.096	0.904
D36.7 Other specified sites	0.096	0.904
D36.0 Lymph nodes	0.096	0.904
C83.3 Large cell (diffuse)	0.096	0.904
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.095	0.905
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.095	0.905
C70 Malignant neoplasm of meninges	0.095	0.905
C69 Malignant neoplasm of eye and adnexa	0.095	0.905
D35.9 Endocrine gland, unspecified	0.094	0.905
D35.8 Pluriglandular involvement	0.094	0.905
D35.7 Other specified endocrine glands	0.094	0.905
D35.6 Aortic body and other paraganglia	0.094	0.905
D35.5 Carotid body	0.094	0.905
D35.4 Pineal gland	0.094	0.905
D35.3 Craniopharyngeal duct	0.094	0.905
D18.1 Lymphangioma, any site	0.094	0.906
D22.1 Melanocytic naevi of eyelid, including canthus	0.094	0.906
D22.7 Melanocytic naevi of lower limb, including hip	0.094	0.906
D35.1 Parathyroid gland	0.094	0.906
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.093	0.906
C38 Malignant neoplasm of heart, mediastinum and pleura	0.093	0.906
C32 Malignant neoplasm of larynx	0.093	0.906
C31 Malignant neoplasm of accessory sinuses	0.093	0.906
C30 Malignant neoplasm of nasal cavity and middle ear	0.093	0.906
C37 Malignant neoplasm of thymus	0.093	0.906
C33 Malignant neoplasm of trachea	0.093	0.906
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.093	0.907
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.093	0.907
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.093	0.907
D47.4 Osteomyelofibrosis	0.093	0.907
D47.2 Monoclonal gammopathy	0.093	0.907
D47.1 Chronic myeloproliferative disease	0.093	0.907
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.093	0.907
C77.9 Lymph node, unspecified	0.093	0.907
C45 Mesothelioma	0.093	0.907
C64 Malignant neoplasm of kidney, except renal pelvis	0.093	0.907
D17.9 Benign lipomatous neoplasm, unspecified	0.091	0.908
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.091	0.908
C49 Malignant neoplasm of other connective and soft tissue	0.091	0.909
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.091	0.909
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.091	0.909
C46 Kaposi's sarcoma	0.091	0.909
D10.9 Pharynx, unspecified	0.091	0.909
D10.7 Hypopharynx	0.091	0.909
D10.6 Nasopharynx	0.091	0.909
D10.5 Other parts of oropharynx	0.091	0.909
D10.4 Tonsil	0.091	0.909
D10.3 Other and unspecified parts of mouth	0.091	0.909
D10.2 Floor of mouth	0.091	0.909
D10.1 Tongue	0.091	0.909
D10.0 Lip	0.091	0.909
D14.4 Respiratory system, unspecified	0.091	0.909
D14.3 Bronchus and lung	0.091	0.909
D14.2 Trachea	0.091	0.909
D14.1 Larynx	0.091	0.909
D14.0 Middle ear, nasal cavity and accessory sinuses	0.091	0.909
D15.9 Intrathoracic organ, unspecified	0.091	0.909
D15.7 Other specified intrathoracic organs	0.091	0.909
D15.2 Mediastinum	0.091	0.909
D15.1 Heart	0.091	0.909
D15.0 Thymus	0.091	0.909
D16.9 Bone and articular cartilage, unspecified	0.091	0.909
D16.8 Pelvic bones, sacrum and coccyx	0.091	0.909
D16.7 Ribs, sternum and clavicle	0.091	0.909
D16.6 Vertebral column	0.091	0.909
D16.5 Lower jaw bone	0.091	0.909
D16.4 Bones of skull and face	0.091	0.909
D16.3 Short bones of lower limb	0.091	0.909
D16.2 Long bones of lower limb	0.091	0.909
D16.1 Short bones of upper limb	0.091	0.909
D16.0 Scapula and long bones of upper limb	0.091	0.909
D19.9 Mesothelial tissue, unspecified	0.091	0.909
D19.7 Mesothelial tissue of other sites	0.091	0.909
D19.1 Mesothelial tissue of peritoneum	0.091	0.909
D19.0 Mesothelial tissue of pleura	0.091	0.909
D20.1 Peritoneum	0.091	0.909
D20.0 Retroperitoneum	0.091	0.909
D26.9 Uterus, unspecified	0.091	0.909
D26.7 Other parts of uterus	0.091	0.909
D26.1 Corpus uteri	0.091	0.909
D26.0 Cervix uteri	0.091	0.909
D29.9 Male genital organ, unspecified	0.091	0.909
D29.7 Other male genital organs	0.091	0.909
D29.4 Scrotum	0.091	0.909
D29.3 Epididymis	0.091	0.909
D29.2 Testis	0.091	0.909
D29.1 Prostate	0.091	0.909
D29.0 Penis	0.091	0.909
D30.9 Urinary organ, unspecified	0.091	0.909
D30.7 Other urinary organs	0.091	0.909
D30.4 Urethra	0.091	0.909
D30.3 Bladder	0.091	0.909
D30.2 Ureter	0.091	0.909
D30.1 Renal pelvis	0.091	0.909
D30.0 Kidney	0.091	0.909
D31.9 Eye, unspecified	0.091	0.909
D31.6 Orbit, unspecified	0.091	0.909
D31.5 Lachrymal gland and duct	0.091	0.909
D31.4 Ciliary body	0.091	0.909
D31.3 Choroid	0.091	0.909
D31.2 Retina	0.091	0.909
D31.1 Cornea	0.091	0.909
D31.0 Conjunctiva	0.091	0.909
C80.9 Malignant neoplasm, unspecified	0.091	0.909
D38.6 Respiratory organ, unspecified	0.091	0.909
D38.5 Other respiratory organs	0.091	0.909
D38.4 Thymus	0.091	0.909
D38.3 Mediastinum	0.091	0.909
D38.2 Pleura	0.091	0.909
D38.0 Larynx	0.091	0.909
D12.2 Ascending colon	0.091	0.909
D23.5 Skin of trunk	0.091	0.909
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.090	0.910
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.090	0.910
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.090	0.910
C97 Malignant neoplasms of independent (primary) multiple sites	0.090	0.910
D35.2 Pituitary gland	0.090	0.910
C26 Malignant neoplasm of other and ill-defined digestive organs	0.089	0.910
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.089	0.910
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.089	0.910
C21 Malignant neoplasm of anus and anal canal	0.089	0.910
C17 Malignant neoplasm of small intestine	0.089	0.910
C23 Malignant neoplasm of gallbladder	0.089	0.910
C16 Malignant neoplasm of stomach	0.089	0.911
D39.9 Female genital organ, unspecified	0.088	0.911
D39.7 Other female genital organs	0.088	0.911
D39.2 Placenta	0.088	0.911
D39.0 Uterus	0.088	0.911
D37.4 Colon	0.088	0.912
C60-C63 Malignant neoplasms of male genital organs	0.088	0.912
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.088	0.912
D04.3 Skin of other and unspecified parts of face	0.088	0.912
C25 Malignant neoplasm of pancreas	0.087	0.913
C79 Secondary malignant neoplasm of other sites	0.087	0.913
D41.4 Bladder	0.087	0.913
D07.5 Prostate	0.087	0.913
C77.1 Intrathoracic lymph nodes	0.087	0.913
C75 Malignant neoplasm of other endocrine glands and related structures	0.086	0.914
C74 Malignant neoplasm of adrenal gland	0.086	0.914
C18 Malignant neoplasm of colon	0.086	0.914
D37.5 Rectum	0.085	0.914
D04.7 Skin of lower limb, including hip	0.085	0.915
D37.9 Digestive organ, unspecified	0.085	0.915
D37.7 Other digestive organs	0.085	0.915
D37.6 Liver, gallbladder and bile ducts	0.085	0.915
D37.3 Appendix	0.085	0.915
D37.2 Small intestine	0.085	0.915
D37.1 Stomach	0.085	0.915
D37.0 Lip, oral cavity and pharynx	0.085	0.915
D06 Carcinoma in situ of cervix uteri	0.085	0.915
D41.9 Urinary organ, unspecified	0.084	0.916
D41.7 Other urinary organs	0.084	0.916
D41.3 Urethra	0.084	0.916
D41.2 Ureter	0.084	0.916
D41.1 Renal pelvis	0.084	0.916
D41.0 Kidney	0.084	0.916
D32.9 Meninges, unspecified	0.084	0.916
D32.1 Spinal meninges	0.084	0.916
D23.9 Skin, unspecified	0.083	0.917
D23.2 Skin of ear and external auricular canal	0.083	0.917
D23.0 Skin of lip	0.083	0.917
D40.9 Male genital organ, unspecified	0.082	0.918
D40.7 Other male genital organs	0.082	0.918
D40.1 Testis	0.082	0.918
D40.0 Prostate	0.082	0.918
D42.9 Meninges, unspecified	0.082	0.918
D42.1 Spinal meninges	0.082	0.918
D42.0 Cerebral meninges	0.082	0.918
D43.9 Central nervous system, unspecified	0.082	0.918
D43.7 Other parts of central nervous system	0.082	0.918
D43.4 Spinal cord	0.082	0.918
D43.3 Cranial nerves	0.082	0.918
D43.2 Brain, unspecified	0.082	0.918
D43.1 Brain, infratentorial	0.082	0.918
D43.0 Brain, supratentorial	0.082	0.918
D44.9 Endocrine gland, unspecified	0.082	0.918
D44.8 Pluriglandular involvement	0.082	0.918
D44.7 Aortic body and other paraganglia	0.082	0.918
D44.6 Carotid body	0.082	0.918
D44.5 Pineal gland	0.082	0.918
D44.4 Craniopharyngeal duct	0.082	0.918
D44.3 Pituitary gland	0.082	0.918
D44.2 Parathyroid gland	0.082	0.918
D44.1 Adrenal gland	0.082	0.918
D44.0 Thyroid gland	0.082	0.918
D46.9 Myelodysplastic syndrome, unspecified	0.082	0.918
D46.7 Other myelodysplastic syndromes	0.082	0.918
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.082	0.918
D46.5 Refractory anaemia with multi-lineage dysplasia	0.082	0.918
D46.4 Refractory anaemia, unspecified	0.082	0.918
D46.3 Refractory anaemia with excess of blasts with transformation	0.082	0.918
D46.2 Refractory anaemia with excess of blasts	0.082	0.918
D46.1 Refractory anaemia with sideroblasts	0.082	0.918
D46.0 Refractory anaemia without sideroblasts, so stated	0.082	0.918
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.082	0.918
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.082	0.918
C83.7 Burkitt's tumour	0.082	0.918
C83.6 Undifferentiated (diffuse)	0.082	0.918
C83.5 Lymphoblastic (diffuse)	0.082	0.918
C83.4 Immunoblastic (diffuse)	0.082	0.918
C83.2 Mixed small and large cell (diffuse)	0.082	0.918
C83.1 Small cleaved cell (diffuse)	0.082	0.918
C83.0 Small cell (diffuse)	0.082	0.918
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.081	0.918
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.081	0.919
C68.9 Urinary organ, unspecified	0.081	0.919
C68.8 Overlapping lesion of urinary organs	0.081	0.919
C68.1 Paraurethral glands	0.081	0.919
C68.0 Urethra	0.081	0.919
C73 Malignant neoplasm of thyroid gland	0.081	0.919
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.081	0.919
D48.7 Other specified sites	0.081	0.919
D48.6 Breast	0.081	0.919
D48.5 Skin	0.081	0.919
D48.4 Peritoneum	0.081	0.919
D48.3 Retroperitoneum	0.081	0.919
D48.2 Peripheral nerves and autonomic nervous system	0.081	0.919
D48.0 Bone and articular cartilage	0.081	0.919
D09.0 Bladder	0.081	0.919
C54.1 Endometrium	0.081	0.919
C15.5 Lower third of oesophagus	0.080	0.920
D04.9 Skin, unspecified	0.080	0.920
D04.8 Skin of other sites	0.080	0.920
D04.6 Skin of upper limb, including shoulder	0.080	0.920
D04.5 Skin of trunk	0.080	0.920
D04.4 Skin of scalp and neck	0.080	0.920
D04.2 Skin of ear and external auricular canal	0.080	0.920
D04.1 Skin of eyelid, including canthus	0.080	0.920
D04.0 Skin of lip	0.080	0.920
C15.9 Oesophagus, unspecified	0.080	0.920
C71.9 Brain, unspecified	0.080	0.920
D48.1 Connective and other soft tissue	0.079	0.921
D07.6 Other and unspecified male genital organs	0.078	0.922
D07.4 Penis	0.078	0.922
D07.3 Other and unspecified female genital organs	0.078	0.922
D07.2 Vagina	0.078	0.922
D07.1 Vulva	0.078	0.922
D07.0 Endometrium	0.078	0.922
D23.4 Skin of scalp and neck	0.077	0.923
D03.5 Melanoma in situ of trunk	0.077	0.923
C76.8 Overlapping lesion of other and ill-defined sites	0.077	0.923
C76.7 Other ill-defined sites	0.077	0.923
C76.5 Lower limb	0.077	0.923
C76.4 Upper limb	0.077	0.923
C76.3 Pelvis	0.077	0.923
C76.2 Abdomen	0.077	0.923
C76.1 Thorax	0.077	0.923
C76.0 Head, face and neck	0.077	0.923
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.076	0.923
C82.6 Cutaneous follicle centre lymphoma	0.076	0.923
C82.5 Diffuse follicle centre lymphoma	0.076	0.923
C82.4 Follicular lymphoma grade IIIb	0.076	0.923
C82.3 Follicular lymphoma grade IIIa	0.076	0.923
C82.2 Large cell, follicular	0.076	0.923
C82.1 Mixed small cleaved and large cell, follicular	0.076	0.923
C82.0 Small cleaved cell, follicular	0.076	0.923
C54.9 Corpus uteri, unspecified	0.076	0.924
C54.8 Overlapping lesion of corpus uteri	0.076	0.924
C54.3 Fundus uteri	0.076	0.924
C54.2 Myometrium	0.076	0.924
C54.0 Isthmus uteri	0.076	0.924
C34.3 Lower lobe, bronchus or lung	0.076	0.924
C91.1 Chronic lymphocytic leukaemia	0.076	0.924
C81.9 Hodgkin's disease, unspecified	0.075	0.924
D22.4 Melanocytic naevi of scalp and neck	0.075	0.924
D09.9 Carcinoma in situ, unspecified	0.075	0.924
D09.7 Carcinoma in situ of other specified sites	0.075	0.924
D09.3 Thyroid and other endocrine glands	0.075	0.924
D09.2 Eye	0.075	0.924
D09.1 Other and unspecified urinary organs	0.075	0.924
C09.9 Tonsil, unspecified	0.075	0.925
D32.0 Cerebral meninges	0.074	0.926
C53.9 Cervix uteri, unspecified	0.074	0.926
C91.9 Lymphoid leukaemia, unspecified	0.074	0.926
C91.8 Mature B-cell leukaemia Burkitt-type	0.074	0.926
C91.7 Other lymphoid leukaemia	0.074	0.926
C91.6 Prolymphocytic leukaemia of T-cell type	0.074	0.926
C91.5 Adult T-cell leukaemia	0.074	0.926
C91.4 Hairy-cell leukaemia	0.074	0.926
C91.3 Prolymphocytic leukaemia	0.074	0.926
C91.2 Subacute lymphocytic leukaemia	0.074	0.926
C91.0 Acute lymphoblastic leukaemia	0.074	0.926
C81.7 Other Hodgkin's disease	0.074	0.926
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.074	0.926
C81.3 Lymphocytic depletion	0.074	0.926
C81.2 Mixed cellularity	0.074	0.926
C81.1 Nodular sclerosis	0.074	0.926
C81.0 Lymphocytic predominance	0.074	0.926
C53.8 Overlapping lesion of cervix uteri	0.074	0.926
C53.1 Exocervix	0.074	0.926
C53.0 Endocervix	0.074	0.926
C92.1 Chronic myeloid leukaemia	0.073	0.926
C51.9 Vulva, unspecified	0.073	0.927
C51.8 Overlapping lesion of vulva	0.073	0.927
C51.2 Clitoris	0.073	0.927
C51.1 Labium minus	0.073	0.927
C51.0 Labium majus	0.073	0.927
C57.9 Female genital organ, unspecified	0.073	0.927
C57.8 Overlapping lesion of female genital organs	0.073	0.927
C57.7 Other specified female genital organs	0.073	0.927
C57.4 Uterine adnexa, unspecified	0.073	0.927
C57.3 Parametrium	0.073	0.927
C57.2 Round ligament	0.073	0.927
C57.1 Broad ligament	0.073	0.927
C57.0 Fallopian tube	0.073	0.927
C15.8 Overlapping lesion of oesophagus	0.073	0.927
C15.4 Middle third of oesophagus	0.073	0.927
C15.3 Upper third of oesophagus	0.073	0.927

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations